Efficient infection of tumor endothelial cells by a capsid-modified adenovirus
- 18 August 2005
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 13 (1) , 52-59
- https://doi.org/10.1038/sj.gt.3302598
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Replicative Oncolytic Adenoviruses in Multimodal Cancer RegimensHuman Gene Therapy, 2003
- Bone marrow-derived, endothelial progenitor-like cells as angiogenesis-selective gene-targeting vectorsGene Therapy, 2003
- Tumor Regression by Targeted Gene Delivery to the NeovasculatureScience, 2002
- Ablating Adenovirus Type 5 Fiber–CAR Binding and HI Loop Insertion of the SIGYPLP Peptide Generate an Endothelial Cell-Selective AdenovirusMolecular Therapy, 2001
- Targeting of Adenovirus to Endothelial Cells by a Bispecific Single-Chain Diabody Directed against the Adenovirus Fiber Knob Domain and Human Endoglin (CD105)Molecular Therapy, 2001
- Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodiesGene Therapy, 2001
- A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancerNature Medicine, 2000
- Expression of Coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriersGene Therapy, 1999
- COMPARISON OF ADENOVIRUS GENE TRANSFER TO VASCULAR ENDOTHELIAL CELLS IN CELL CULTURE, ORGAN CULTURE, AND IN VIVO1Transplantation, 1996
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996